Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients

Clinical Nutrition

Volumn 31, Issue 4, 2012, Pages 567-570

  Touré, Abdoulaye ^a   Lauverjat, Madeleine ^b   Peraldi, Catherine ^b   Boncompain Gerard, Michèle ^b   Gelas, Patrick ^b   Barnoud, Didier ^b   Chambrier, Cécile ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Home parenteral nutrition; Septicemia; Taurolidine

Indexed keywords

CITRIC ACID; TAUROLIDINE; TAUROLOCK; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; FEMALE; HIGH RISK PATIENT; HOME CARE; HUMAN; INFECTION PREVENTION; MALE; RETROSPECTIVE STUDY; STANDARDIZATION; TOTAL PARENTERAL NUTRITION;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PARENTERAL NUTRITION, HOME; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; SOLUTIONS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; TAURINE; THIADIAZINES; YOUNG ADULT;

EID: 84864146632     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.01.001     Document Type: Article

References (25)

1. Santarpia L., Alfonsi L., Tiseo D., Creti R., Baldassarri L., Pasanisi F., et al. Central venous catheter infections and antibiotic therapy during long-term home parenteral nutrition: an 11-year follow-up study. J Parenter Enteral Nutr 2010, 34:254-262.
2. Shah C.B., Mittelman M.W., Costerton J.W., Parenteau S., Pelak M., Arsenault R., et al. Antimicrobial activity of a novel catheter locks solution. Antimicrob Agents Chemother 2002, 46:1674-1679.
3. Jurewitsch B., Jeejeebhoy K.N. Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections. Clin Nutr 2005, 24:462-465.
4. O'Grady N.P., Alexander M., Burns L.A., Dellinger P., Garland J., Heard S.O., et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011, 52:e162-e193.
5. Pittiruti M., Hamilton H., Biffi R., MacFie J., Pertkiewicz M. ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr 2009, 28:365-377.
6. Santarpia L., Pasanisi F., Alfonsi L., Violante G., Tiso D., Simone G., et al. Prevention and treatment of implanted central venous catheter (CVC)-related sepsis: a report after six years of home parenteral nutrition (HPN). Clin Nutr 2002, 21:207-211.
7. Opilla M. Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 2008, 36(S173):e5-8.
8. Forchielli M.L., Gura K., Anessi-Pessina E., Richardson D., Cai W., Lo C.W. Success rates and cost-effectiveness of antibiotic combinations for initial treatment of central-venous-line infections during total parenteral nutrition. J Parenter Enteral Nutr 2000, 24:119-125.
9. Shirotani N., Iino T., Numata K., Kameoka S. Complications of central venous catheters in patients on home parenteral nutrition: an analysis of 68 patients over 16 years. Surg Today 2006, 36:420-424.
10. Bradshaw J.H., Puntis J.W.L. Taurolidine and catheter-related bloodstream infection: a systematic review of the literature. J Parenter Enteral Nutr 2008, 47:179-186.
11. Opilla M.T., Kirby D.F., Edmond M.B. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. J Parenter Enteral Nutr 2007, 31:302-305.
12. Bisseling T.M., Willems M.C., Versleijen M.W., Hendriks J.C., Vissers R.K., Wanten G.J. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr 2010, 29:464-468.
13. Simon A., Ammann R.A., Wiszniewsky G., Bode U., Fleischhack G., Besuden M.M. Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infect Dis 2008, 8:1-8.
14. Cullis P.S., McKee R.F. Taurolidine lock - experience from the west of Scotland. Clin Nutr 2011, 30:399-400.
15. Mermel L.A., Allon M., Bouza E. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
16. Jurewitsch B., Lee T., Park J., Jeejeebhoy K. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. J Parenter Enteral Nutr 1998, 22:242-244.
17. Betjes M.G.H., Van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004, 19:1546-1551.
18. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003, 36:1539-1544.
19. Taylor C., Cahill J., Gerrish M., Little J. A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients. J Ren Care 2008, 34:116-120.
20. ® and CLSTM (a new antimicrobial lock solution). Blood Purif 2001, 19:251-254.
21. Yahav D., Rozen-Zvi B., Gafter-Gvili A., Leibovici L., Gafter U., Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008, 47:83-93.
22. Torres-Viera C., Thauvin-Eliopoulos C., Souli M., DeGirolami M.P., Farris M.G., Wennersten C.B., et al. Activities of taurolidine in vitro and in experimental Enterococcal endocarditis. Antimicrob Agents Chemother 2000, 44:1720-1724.
23. Weijmer1 M.C., Debets-Ossenkopp Y.J., van de Vondervoort F.J., Ter Wee P.M. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 2002, 17:2189-2195.
24. Koldehoff M., Zakrzewski J.L. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 2004, 24:491-495.
25. Evans H.L., Dellit T.H., Chan J., Nathens A.B., Maier R.V., Cuschieri J. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg 2010, 145:240-246.